Rabies and rabies-research: Past, present and future

被引:55
作者
Fu, ZF
机构
关键词
rabies vaccine; dog rabies; wildlife rabies;
D O I
10.1016/S0264-410X(96)00312-X
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Rabies is probably the oldest recorded infection of mankind. The development of the first rabies vaccine by Pasteur surely had been hoped to eliminate or at least drastically reduce its incidence. However, this goal has not been achieved because rabies is maintained in many animal reservoirs, including both domestic and wild. There are still many aspects of the pathogenicity of rabies that are unknown. For example, we have no explanation for the long incubation period (up to 6 years). Furthermore, new patterns of rabies infection present a problem for epidemiologists and virologists alike. There are several cases of human rabies in which there was no history of a bite. Despite these continuing problems, there has been tremendous progress in the control of rabies. Cheap and safe vaccines for animals as well as humans have been developed. Oral vaccination of wildlife with recombinant rabies virus vaccines is beginning to reduce the incidence of rabies among foxes and raccoons. Vaccination of stray dogs could lead to the eradication of rabies in countries where dog rabies is the sole source of human exposure. (C) 1997 Elsevier Science Ltd.
引用
收藏
页码:S20 / S24
页数:5
相关论文
共 21 条
  • [1] EFFECT OF NEUROTROPIC VIRUS-INFECTION ON NEURONAL AND INDUCIBLE NITRIC-OXIDE SYNTHASE ACTIVITY IN RAT-BRAIN
    AKAIKE, T
    WEIHE, E
    SCHAEFER, M
    FU, ZF
    ZHENG, YM
    VOGEL, W
    SCHMIDT, H
    KOPROWSKI, H
    DIETZSCHOLD, B
    [J]. JOURNAL OF NEUROVIROLOGY, 1995, 1 (01) : 118 - 125
  • [2] BALTAZARD M, 1955, Bull World Health Organ, V13, P747
  • [3] LARGE-SCALE ERADICATION OF RABIES USING RECOMBINANT VACCINIA RABIES VACCINE
    BROCHIER, B
    KIENY, MP
    COSTY, F
    COPPENS, P
    BAUDUIN, B
    LECOCQ, JP
    LANGUET, B
    CHAPPUIS, G
    DESMETTRE, P
    AFIADEMANYO, K
    LIBOIS, R
    PASTORET, PP
    [J]. NATURE, 1991, 354 (6354) : 520 - 522
  • [4] RABIES VIRUS SELECTIVELY ALTERS 5-HT(1) RECEPTOR SUBTYPES IN RAT-BRAIN
    CECCALDI, PE
    FILLION, MP
    ERMINE, A
    TSIANG, H
    FILLION, G
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY-MOLECULAR PHARMACOLOGY SECTION, 1993, 245 (02): : 129 - 138
  • [5] STRUCTURAL AND IMMUNOLOGICAL CHARACTERIZATION OF A LINEAR VIRUS-NEUTRALIZING EPITOPE OF THE RABIES VIRUS GLYCOPROTEIN AND ITS POSSIBLE USE IN A SYNTHETIC VACCINE
    DIETZSCHOLD, B
    GORE, M
    MARCHADIER, D
    NIU, HS
    BUNSCHOTEN, HM
    OTVOS, L
    WUNNER, WH
    ERTL, HCJ
    OSTERHAUS, ADME
    KOPROWSKI, H
    [J]. JOURNAL OF VIROLOGY, 1990, 64 (08) : 3804 - 3809
  • [6] DIETZSCHOLD B, 1996, FIELDS VIROLOGY, P1137
  • [7] Flamand A, 1993, Trends Microbiol, V1, P317, DOI 10.1016/0966-842X(93)90010-O
  • [8] Inhibition of rabies virus infection by an oligodeoxynucleotide complementary to rabies virus genomic RNA
    Fu, ZF
    Wickstrom, E
    Jiang, M
    Corisdeo, S
    Yang, J
    Dietzschold, B
    Koprowski, H
    [J]. ANTISENSE & NUCLEIC ACID DRUG DEVELOPMENT, 1996, 6 (02): : 87 - 93
  • [9] FU ZF, 1995, J VIROL, V67, P6674
  • [10] LOCAL NITRIC-OXIDE PRODUCTION IN VIRAL AND AUTOIMMUNE-DISEASES OF THE CENTRAL-NERVOUS-SYSTEM
    HOOPER, DC
    OHNISHI, ST
    KEAN, R
    NUMAGAMI, Y
    DIETZSCHOLD, B
    KOPROWSKI, H
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (12) : 5312 - 5316